Walgreens Boots Alliance Inc. reported a fiscal first-quarter net loss of $265 million, or 31 cents per share, for the period ended November 30, 2024, compared to a net loss of $67 million, or 8 cents per share, in the same period the previous year. Despite the loss, the company's adjusted earnings per share of 51 cents beat Wall Street expectations of 38 cents, and revenue rose 7.5% to $39.5 billion, surpassing the consensus estimate of $37.4 billion. The company's performance was driven by growth across all business segments, with U.S. retail pharmacy sales increasing 6.6% to $30.9 billion, international sales growing 10.2% to $6.4 billion, and U.S. healthcare sales rising 12% to $2.2 billion. Walgreens is in the process of closing about 450 low-performing U.S. stores as part of its turnaround strategy, which CEO Tim Wentworth described as showing 'early progress' toward a sustainable, retail pharmacy-led operating model. The company reaffirmed its fiscal 2025 adjusted earnings guidance of $1.40 to $1.80 per share, despite not providing an annual sales outlook. Walgreens shares surged more than 27% following the earnings report, reflecting investor optimism about the company's strategic direction.